Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Gore

Showing results (51-60 of 314) with videos related to

Pageof 32
Sort By:
Endocrinology|March 1, 1981
Differential effects of luteinizing hormone-releasing hormone on follicle-stimulating hormone-dependent responses in rat granulosa cells and Sertoli cells in vitroR E Gore-Langton, M Lacroix, J H Dorrington
The Journal of Organic Chemistry|August 20, 1976
Synthesis and absolute configuration of multistriatinG T Pearce, W E Gore, R M Silverstein
European Journal of Cancer (Oxford, England : 1990)|October 3, 2008
Recent advances in the treatment of renal cell carcinoma and the role of targeted therapiesSimon Chowdhury, James M G Larkin, Martin E Gore
European Journal of Cancer (Oxford, England : 1990)|June 1, 1997
A phase II study of continuous infusional 5-fluorouracil (5-FU) and subcutaneous interleukin-2 (IL-2) in metastatic renal cancerP Savage, D Costelna, J Moore, et al.
British Journal of Cancer|December 1, 1983
Antibody-dependent-cellular-cytotoxicity against cultured human breast cancer cells mediated by human effector cells using monoclonal and polyclonal antibodiesM E Gore, R A Skilton, R C Coombes
Seminars in Oncology|February 1, 1997
Taxane/platinum/anthracycline combination therapy in advanced epithelial ovarian cancerM Hill, V Macfarlane, J Moore, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1995
Comparison of high dose-rate and low dose-rate dose distributions for vaginal cylindersE Gore, M T Gillin, K Albano, et al.
Seminars in Oncology|February 1, 1992
Future directions with carboplatin: can therapeutic monitoring, high-dose administration, and hematologic support with growth factors expand the spectrum compared with cisplatin?A H Calvert, D R Newell, M E Gore
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Unexpected toxicity of combination thalidomide and interferon alpha-2a treatment in metastatic renal cell carcinomaP D Nathan, M E Gore, T G Eisen
The American Journal of Physiology|November 1, 1987
Adhesion and differentiation of cultured rat granulosa cells: role of fibronectinP Morley, D T Armstrong, R E Gore-Langton
Pageof 32

Showing results (51-60 of 314) with videos related to

Sort By:
Pageof 32
Endocrinology|March 1, 1981
Differential effects of luteinizing hormone-releasing hormone on follicle-stimulating hormone-dependent responses in rat granulosa cells and Sertoli cells in vitroR E Gore-Langton, M Lacroix, J H Dorrington
The Journal of Organic Chemistry|August 20, 1976
Synthesis and absolute configuration of multistriatinG T Pearce, W E Gore, R M Silverstein
European Journal of Cancer (Oxford, England : 1990)|October 3, 2008
Recent advances in the treatment of renal cell carcinoma and the role of targeted therapiesSimon Chowdhury, James M G Larkin, Martin E Gore
European Journal of Cancer (Oxford, England : 1990)|June 1, 1997
A phase II study of continuous infusional 5-fluorouracil (5-FU) and subcutaneous interleukin-2 (IL-2) in metastatic renal cancerP Savage, D Costelna, J Moore, et al.
British Journal of Cancer|December 1, 1983
Antibody-dependent-cellular-cytotoxicity against cultured human breast cancer cells mediated by human effector cells using monoclonal and polyclonal antibodiesM E Gore, R A Skilton, R C Coombes
Seminars in Oncology|February 1, 1997
Taxane/platinum/anthracycline combination therapy in advanced epithelial ovarian cancerM Hill, V Macfarlane, J Moore, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1995
Comparison of high dose-rate and low dose-rate dose distributions for vaginal cylindersE Gore, M T Gillin, K Albano, et al.
Seminars in Oncology|February 1, 1992
Future directions with carboplatin: can therapeutic monitoring, high-dose administration, and hematologic support with growth factors expand the spectrum compared with cisplatin?A H Calvert, D R Newell, M E Gore
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Unexpected toxicity of combination thalidomide and interferon alpha-2a treatment in metastatic renal cell carcinomaP D Nathan, M E Gore, T G Eisen
The American Journal of Physiology|November 1, 1987
Adhesion and differentiation of cultured rat granulosa cells: role of fibronectinP Morley, D T Armstrong, R E Gore-Langton
Pageof 32